Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1978 Aug;31(8):779–783. doi: 10.1136/jcp.31.8.779

A clinicopathological study of liver disease in haemophiliacs.

P M Mannucci, G Ronchi, L Rota, M Colombo
PMCID: PMC1145406  PMID: 690243

Abstract

Chronic liver disease is not often reported in patients with haemophilia. Although a high incidence of abnormal liver function tests has been reported, the clinical significance of these findings and their relation to chronic liver disease cannot be established without a liver biopsy. The results of this procedure, carried out in 11 patients with severe haemophilia A and B, in whom SGOT had been persistently raised for three years, are reported. Five patients had chronic active hepatitis, four had chronic persistent hepatitis, one had cirrhosis, and one alcoholic hepatitis. No haemorrhagic complication followed the biopsy procedure, which was carried out in patients given prophylactic clotting factor concentrates. These results suggest that duration of abnormal liver function tests is likely to represent liver disease in haemophiliacs, and that biopsy should be considered to establish the diagnosis and plan a suitable therapeutic programme.

Full text

PDF
782

Images in this article

781Fig. 1
on p.781
782Fig. 2
on p.782

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cook G. C., Mulligan R., Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med. 1971 Apr;40(158):159–185. doi: 10.1093/oxfordjournals.qjmed.a067264. [DOI] [PubMed] [Google Scholar]
  2. De Groote J., Desmet V. J., Gedigk P., Korb G., Popper H., Poulsen H., Scheuer P. J., Schmid M., Thaler H., Uehlinger E. A classification of chronic hepatitis. Lancet. 1968 Sep 14;2(7568):626–628. doi: 10.1016/s0140-6736(68)90710-1. [DOI] [PubMed] [Google Scholar]
  3. Grady G. Editorial: Tolerating hepatitis. N Engl J Med. 1974 Jun 11;291(2):96–97. doi: 10.1056/NEJM197407112910212. [DOI] [PubMed] [Google Scholar]
  4. Hasiba U., Spero J. A., Lewis J. H. Chronic hepatitis in hemophilia. Scand J Haematol Suppl. 1977;30:27–32. doi: 10.1111/j.1600-0609.1977.tb01514.x. [DOI] [PubMed] [Google Scholar]
  5. Hilgartner M. W., Giardina P. Liver dysfunction in patients with hemophilia. Scand J Haematol Suppl. 1977;30:6–10. doi: 10.1111/j.1600-0609.1977.tb01511.x. [DOI] [PubMed] [Google Scholar]
  6. Lesesne H. R., Morgan J. E., Blatt P. M., Webster W. P., Roberts H. R. Liver biopsy in hemophilia A. Ann Intern Med. 1977 Jun;86(6):703–707. doi: 10.7326/0003-4819-86-6-703. [DOI] [PubMed] [Google Scholar]
  7. London W. T., Di Figlia M., Sutnick A., Blumberg B. S. An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response. N Engl J Med. 1969 Sep 11;281(11):571–578. doi: 10.1056/NEJM196909112811101. [DOI] [PubMed] [Google Scholar]
  8. Mannucci P. M., Capitanio A., Del Ninno E., Colombo M., Pareti F., Ruggeri Z. M. Asymptomatic liver disease in haemophiliacs. J Clin Pathol. 1975 Aug;28(8):620–624. doi: 10.1136/jcp.28.8.620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Schalm S. W., Summerskill W. H., Gitnick G. L., Elveback L. R. Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen. Gut. 1976 Oct;17(10):781–786. doi: 10.1136/gut.17.10.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sherlock S. Chronic hepatitis. Gut. 1974 Jul;15(7):581–597. doi: 10.1136/gut.15.7.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Simon J. B., Patel S. K. Liver diseases in asymptomatic carriers of hepatitis B antigen. Gastroenterology. 1974 May;66(5):1020–1028. [PubMed] [Google Scholar]
  12. Strauss H. S., Merler E. Characterization and properties of an inhibitor of factor 8 in the plasma of patients with hemophilia A following repeated transfusions. Blood. 1967 Aug;30(2):137–150. [PubMed] [Google Scholar]
  13. Summerskill W. H., Korman M. G., Ammon H. V., Baggenstoss A. H. Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut. 1975 Nov;16(11):876–883. doi: 10.1136/gut.16.11.876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Woolf I. L., Boyes B. E., Jones D. M., Whittaker J. S., Tapp E., MacSween R. N., Renton P. H., Stratton F., Dymock I. W. Asymptomatic liver disease in hepatitis B antigen carriers. J Clin Pathol. 1974 May;27(5):348–352. doi: 10.1136/jcp.27.5.348. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES